Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries
source: shutterstock.com

Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries

Scientists at London’s University College and a team of scientists at Stanford University simultaneously made the same discovery about amyotrophic lateral sclerosis (ALS): the genetic variant in the protein UNC13A…

Continue Reading Two ALS Studies May Unravel its Genetic Roots and Solve One of its Mysteries
Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center
rawpixel / Pixabay

Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center

According to a recent article, Trialbee and ERGOMED have partnered to become the platform for patient recruitment for their new Rare Disease Innovation Center. Trialbee Trialbee is the leading platform…

Continue Reading Trialbee and ERGOMED Have Partnered to Recruit Patients for New Rare Disease Innovation Center
Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer
jarmoluk / Pixabay

Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer

According to a recent article, researchers have found that adding durvalumab to chemotherapy treatments results in prolonged survival rates in patients with advanced biliary tract cancer. Biliary Tract Cancer Biliary…

Continue Reading Adding Durvalumab to Chemotherapy Extends Survival in Patients with Advanced Biliary Tract Cancer